Table 1 Phenotypic characteristics of patients with tuberous sclerosis complex in this study.

From: Genotype-phenotype correlation of renal lesions in the tuberous sclerosis complex

Characteristic

All (N = 30)

TSC1 (N = 4)

TSC2 (N = 23)

NMI (N = 3)

Median age, years (range)

24 (14–28)

21.5 (16.3–28)

22 (11.3–27.3)

34 (30.5–39.5)

Gender

Male (%)

12 (40.0)

1 (25.0)

11 (47.8)

0 (0)

Female (%)

18 (60.0)

3 (75.0)

12 (52.1)

3 (100)

Hypomelanotic macules (%)

9 (30.0)

2 (50.0)

6 (26.1)

1 (33.3)

Angiofibromas (%)

20 (66.7)

1 (25.0)

17 (73.9)

2 (66.7)

Ungual fibromas (%)

9 (30.0)

1 (25.0)

7 (30.4)

1 (33.3)

Shagreen patch (%)

5 (17.2)

1 (33.3)

4 (17.4)

0 (0)

Multiple retinal hamartomas (%)

7 (23.3)

0 (0)

7 (30.4)

0 (0)

Cortical tuber (%)

26 (86.7)

4 (100)

21 (91.3)

1 (33.3)

SEN (%)

26 (86.7)

4 (100)

21 (91.3)

1 (33.3)

SEGA (%)

4 (13.3)

1 (25.0)

3 (13.0)

0 (0)

Cardiac rhabdomyoma (%)

6 (20.0)

0 (0)

6 (26.1)

0 (0)

LAM (%)

11 (36.7)

1 (25.0)

8 (34.8)

2 (66.7)

AML (%)

26 (86.7)

3 (75.0)

20 (87.0)

3 (100)

Renal cyst (%)

12 (40.0)

4 (100)

8 (34.8)

0 (0)

AML maximum diameter, cm, median (range)

3.6 (2.0–8.9)

1.7 (0.8–3.7)

3.4 (2.1–8.9)

9 (8.7–10.3)

  1. AML angiomyolipoma, LAM Lymphangiomyomatosis, NMI no mutation identified, SEGA subependymal giant cell astrocytoma, SEN subependymal nodule.